{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T22:46:54Z","timestamp":1774392414303,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jfma.2026.03.066","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:36:09Z","timestamp":1774388169000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u201cPhysicians, case managers, and HCV patients recommend a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus infection with DAA therapies\u201d"],"prefix":"10.1016","author":[{"given":"Ravindra","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kartik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2026.03.066_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfma.2026.01.064","article-title":"Physicians, case managers, and HCV patients recommend a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus infection with DAA therapies","author":"Liu","year":"2026","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2026.03.066_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/ijh\/9918357","article-title":"Efficacy of sofosbuvir\u2013velpatasvir\u2013ribavirin regimen for retreatment of chronic hepatitis C in patients with prior DAA failure: a retrospective study from a national treatment center","author":"Singh","year":"2025","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.jfma.2026.03.066_bib3","article-title":"Large simple randomized controlled trials\u2014from drugs to medical devices: lessons from recent experience","author":"Buccheri","year":"2025","journal-title":"Trials"},{"key":"10.1016\/j.jfma.2026.03.066_bib4","first-page":"2118","article-title":"Potential drug interactions in liver cirrhosis: patterns and sociodemographic factors","author":"Amni","year":"2025","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.jfma.2026.03.066_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.46747\/cfp.7106417","article-title":"Administrative burden in primary care","volume":"71","author":"Storseth","year":"2025","journal-title":"Can Fam Physician"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626002366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664626002366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:36:10Z","timestamp":1774388170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664626002366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":5,"alternative-id":["S0929664626002366"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2026.03.066","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201cPhysicians, case managers, and HCV patients recommend a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus infection with DAA therapies\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2026.03.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}